The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey-Reference-Cited by-同舟云学术

The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey

Published:2018 Issue:3 Volume:27 Page:
ISSN:1318-4458
Container-title:Acta Dermatovenerologica Alpina Pannonica et Adriatica
language:en
Short-container-title:

Author:

Bulur Isil,Bulbul Baskan Emel,Ozdemir Mustafa,Balevi Ali,Kocatürk Göncü Emek,Altunay Ilknur,Gönül Müzeyyen,Ergin Can,Ertam İlgen,Erdoğan Hilal Kaya,Bilgin Muzaffer,Mustafa Teoman Muzaffer

Publisher

Association of Slovenian Dermatovenerologists

Subject

Infectious Diseases,Dermatology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement;International Journal of Dermatology;2024-07-04

2. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema;Journal of the European Academy of Dermatology and Venereology;2024-06-10

3. Omalizumab treatment for chronic spontaneous urticaria: data from Turkey;Advances in Dermatology and Allergology;2022

4. Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria;International Archives of Allergy and Immunology;2022

5. Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review;Allergy, Asthma & Clinical Immunology;2020-08-04